<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(2)</volume><submitter>Wang M</submitter><funding>National Centre for the Replacement, Refinement and Reduction of Animals in Research</funding><funding>NIBIB NIH HHS</funding><funding>European Union</funding><funding>Brigham Research Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pubmed_abstract>Three-dimensional (3D) bioprinting has emerged as an enabling tool for various biomedical applications, such as tissue regeneration and tissue model engineering. To this end, the development of bioinks with multiple functions plays a crucial role in the applications of 3D bioprinting technologies. In this study, we propose a new bioink based on two immiscible aqueous phases of gelatin methacryloyl (GelMA) and dextran, further endowed with anti-bacterial and anti-inflammatory properties. This micropore-forming GelMA-dextran (PGelDex) bioink exhibited excellent printability with vat-polymerization, extrusion, and handheld bioprinting methods. The porous structure was confirmed after bioprinting, which promoted the spreading of the encapsulated cells, exhibiting the exceptional cytocompatibil</pubmed_abstract><journal>Biofabrication</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8962756</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A multifunctional micropore-forming bioink with enhanced anti-bacterial and anti-inflammatory properties.</pubmed_title><pmcid>PMC8962756</pmcid><funding_grant_id>R01 EB028143</funding_grant_id><funding_grant_id>NA</funding_grant_id><funding_grant_id>NC/K500318/1</funding_grant_id><funding_grant_id>CBET-EBMS-123859</funding_grant_id><funding_grant_id>R01 GM134036</funding_grant_id><funding_grant_id>R21 EB025270</funding_grant_id><funding_grant_id>R21 EB026175</funding_grant_id><funding_grant_id>R00CA201603</funding_grant_id><funding_grant_id>760921</funding_grant_id><funding_grant_id>R00 CA201603</funding_grant_id><pubmed_authors>Mu X</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Tang G</pubmed_authors><pubmed_authors>Kuang X</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Jiang Z</pubmed_authors><pubmed_authors>Lian L</pubmed_authors><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Ghaemmaghami AM</pubmed_authors><pubmed_authors>Zhang YS</pubmed_authors><pubmed_authors>Flores RS</pubmed_authors><pubmed_authors>Japo JO</pubmed_authors></additional><is_claimable>false</is_claimable><name>A multifunctional micropore-forming bioink with enhanced anti-bacterial and anti-inflammatory properties.</name><description>Three-dimensional (3D) bioprinting has emerged as an enabling tool for various biomedical applications, such as tissue regeneration and tissue model engineering. To this end, the development of bioinks with multiple functions plays a crucial role in the applications of 3D bioprinting technologies. In this study, we propose a new bioink based on two immiscible aqueous phases of gelatin methacryloyl (GelMA) and dextran, further endowed with anti-bacterial and anti-inflammatory properties. This micropore-forming GelMA-dextran (PGelDex) bioink exhibited excellent printability with vat-polymerization, extrusion, and handheld bioprinting methods. The porous structure was confirmed after bioprinting, which promoted the spreading of the encapsulated cells, exhibiting the exceptional cytocompatibil</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-18T22:56:10.239Z</modification><creation>2025-04-07T10:38:34.559Z</creation></dates><accession>S-EPMC8962756</accession><cross_references><pubmed>35226880</pubmed><doi>10.1088/1758-5090/ac5936</doi></cross_references></HashMap>